The Center for Global Health Policy’s “Science Speaks” blog notes that PEPFAR recently released its 8th annual report (.pdf) to Congress. “The five-page document outlines the program’s progress as of the end of fiscal year 2011 in various areas,” including the provision of antiretroviral treatment, care, and support; HIV testing and counseling for pregnant women; and prevention of mother-to-child transmission services, the blog notes. The report includes sections on “leading with science,” “smart investments,” “country ownership,” and “shared responsibility,” according to the blog (Mazzotta, 5/4).
“While the battle against HIV/AIDS attracts more donor funding globally than all other diseases combined, it has not diverted attention from fighting unrelated afflictions — such as malaria, measles and malnutrition — and may be improving health services overall in targeted countries, according to a study on Rwanda published” Wednesday in the American Journal of Tropical Medicine and Hygiene, an American Society of Tropical Medicine and Hygiene (ASTMH) press release reports. “A six-year investigation of health clinics in Rwanda by researchers at Brandeis University infuses fresh evidence into a long-standing debate about whether the intensive focus on HIV/AIDS, which in 2010 alone killed 1.8 million people, is undermining other health services, particularly in African countries that are at the epicenter of the pandemic,” the press release states (5/2).
“In public comments [.pdf] submitted this week, a group of 14 leading HIV/AIDS and health organizations stated their support for Food and Drug Administration (FDA) approval of emtricitabine/tenofovir disoproxil fumarate [TDF/FTC] … as pre-exposure prophylaxis (PrEP) to prevent HIV infection in adult men and women,” a press release from AVAC: Global Advocacy for HIV Prevention states. “Modeling studies have shown that widespread access to PrEP could reduce new HIV infections, and thus the scale of the global HIV epidemic, substantially around the world,” the press release says, adding, “The FDA’s decision on TDF/FTC as PrEP could help pave the way for global health funders and developing countries to step up their planning for implementation” (5/1).
The Center for Global Health Policy’s “Science Speaks” blog rounds up results presented at a late breaker session at last week’s 2nd International Treatment as Prevention Workshop in Vancouver. The blog notes the session “offered some interesting insights relevant to HIV treatment scale up” (Lubinski, 4/30).
“Each year, nearly 400,000 children are born with HIV globally, and prevention of mother-to-child transmission (PMTCT) is a particular challenge in sub-Saharan Africa, an area characterized by weak health systems,” U.S. Global AIDS Coordinator Ambassador Eric Goosby writes in the State Department “DipNote” blog. “Last year PEPFAR and UNAIDS joined with other partners to launch the Global Plan, an initiative to eliminate new HIV infections among children and keep their mothers alive,” Goosby writes and reflects on a two-day mission to Nigeria with UNAIDS Executive Director Michel Sidibe last week. He concludes, “Preventing new HIV infections in children is a smart investment that saves lives, and the United States is proud to partner with Nigeria and other countries in this cause” (4/30).
“The world is falling behind in its pledge to reduce HIV/AIDS infections and improve treatment, especially in sub-Saharan Africa, according to a U.N. report [.pdf] released Monday” by U.N. Secretary-General Ban Ki-moon, the Associated Press reports. The report to the U.N. General Assembly “said that ‘critical challenges remain’ if the world is to make good on promises made at a U.N.-sponsored meeting on HIV/AIDS in June 2011,” the AP writes (Alt Powell, 4/30). “Among the targets set by the international community at the June 2011 high-level meeting are the elimination of new HIV/AIDS infections in children, cutting sexually transmitted infections by 50 percent, and delivering antiretroviral therapy to 15 million people,” Xinhua/China Daily notes (5/1).
U.N. Secretary-General Ban Ki-moon on Thursday during travel to India met with Indian Minister of Health and Family Welfare Ghulam Nazi Azad and “commend[ed] the country’s progress on health,” its “continued efforts towards achieving universal health coverage,” and its “commitment to the Global Strategy on Women’s and Children’s Health,” highlighting “its innovative programs in this area” and “the need to do more to promote the well-being of women and children,” the U.N. News Centre reports (4/26). Recognizing the “work still to be done to achieve the Millennium Development Goals, Ban said he would like to showcase India’s experiences and best practices in dealing with maternal and child health issues for others to follow,” according to the IANS/Daily News. Ban also “said [U.N.] member nations … are ready to help India in dealing with polio, malaria, tetanus, measles and HIV transmission-related mortality,” the news service notes (4/26).
The Center for Global Health Policy’s “Science Speaks” blog continued its coverage of the 2nd International Treatment as Prevention Workshop in Vancouver. One post describes a presentation by Zunyou Wu, director of the Chinese Center for Disease Control and Prevention (CDC), who “offered … new information about China’s response to new evidence on treatment as prevention” (Lubinski, 4/25). A second post discusses a presentation by Vladimir Novitsky of the Harvard School of Public Health, who “offered … a snapshot of a four-year treatment as prevention study planned for Botswana (Lubinski, 4/25). “Chewe Luo, a senior adviser for UNICEF, discussed efforts to eliminate vertical HIV transmission from the perspective of treatment as prevention,” according to a third post (Lubinski, 4/26). Finally, Stephen Lawn of the London School of Hygiene and Tropical Medicine “reminded the audience … that antiretroviral therapy (ART) goes a long way to protect HIV-infected individuals from tuberculosis (TB),” a fourth post notes (Lubinski, 4/26).
“Southern African governments could use public spending in their battle against the extremely high rates of HIV/AIDS in their countries and still achieve a positive economic impact, argues a new paper [.pdf] from the African Development Bank (AfDB),” an AfDB press release states. The paper, titled “The Role of Fiscal Policy in Tackling the HIV/AIDS Epidemic in Southern Africa,” examines the cases of Botswana, Lesotho, and Swaziland, which have the highest adult HIV prevalence in the world, and says these countries could increase productivity and gross domestic product (GDP) through “[g]overnment fiscal action on HIV/AIDS treatment,” according to the press release. “Acting optimally, the debt burden of Botswana, Lesotho and Swaziland could be alleviated by five percent, one percent and 13 percent of GDP respectively, says the report,” the press release states (4/25).
“More than 400 Kenyan AIDS activists have demonstrated in the capital, Nairobi, demanding that the U.S. President’s Emergency Plan for AIDS Relief release some $500 million for HIV programs in Kenya that is stuck in the pipeline,” PlusNews reports. “The U.S. government recently revealed that close to $1.5 billion has been in the global PEPFAR pipeline for more than 18 months,” the news service notes, adding that the allocation to Kenya is the largest. According to the news service, “The protestors presented a memorandum listing their demands to U.S. Ambassador to Kenya Scott Gration, head of PEPFAR-Kenya Katherine Perry, Kenya’s Director of Public Health Shahnaz Sharif, and other senior Ministry of Health officials.”